Vasiliki Labropoulou

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

Eirini Katodritou, Evangelos Terpos, Sossana Delimpasi et al. · Blood Cancer Journal · 2018 · 49 citations · Full text

Medicine, Hematology, Oncology +14

Improved survival of patients with primary plasma cell leukemia with <scp>VRd</scp> or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group

Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira et al. · American Journal of Hematology · 2023 · 26 citations · Full text

Medicine, Hematology, Oncology +13

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The <scp>DARE</scp> study

Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis et al. · American Journal of Hematology · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group

Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi et al. · American Journal of Hematology · 2024 · 16 citations · Full text

Medicine, Hematology, Oncology +16